Nepro® HP Vanilla flavor 220mL
NEPRO HP (HIGH PROTEIN)
SCIENTIFICALLY DESIGNED TO MEET THE NUTRIENT NEEDS FOR PEOPLE ON DIALYSIS
- Complete renal nutrition for oral or tube feeding, as supplement or sole source nutrition
- Unique KidneyCare System with heart healthy fat blend, low-GI§ CARBSTEADY® system and modified electrolytes (low phosphorus, potassium, sodium) to improve nutritional status and outcomes of CKD patients
- High in calories (1.82kcal/ml) and protein (17.82g/220ml)
- Help improve nutrition status and levels of serum albumin & prealbumin in patient on dialysis1,2
IMPORTED FROM THE NETHERLANDS
Ingredients
Water, maltodextrin, VEGETABLE OIL (high oleic sunflower oil, canola oil), CASEINATES (calcium caseinate, magnesium caseinate, sodium caseinate), milk protein isolate, sucrose, glycerine, fructo-oligosaccharides (FOS), MINERALS (potassium citrate, sodium citrate, sodium chloride, calcium citrate, magnesium sulphate, ferrous sulphate, zinc sulphate, cupric sulphate, manganese sulphate, potassium iodide, chromium chloride, sodium molybdate, sodium selenate), emulsifier (322), flavouring, choline chloride, stabiliser (460), I-carnitine, VITAMINS (ascorbic acid, niacinamide, calcium pantothenate, pyridoxine hydrochloride, thiamin hydrochloride, riboflavin, Vitamin E, Vitamin A palmitate, folic acid, biotin, phylloquinone, Vitamin D3, cyanocobalamin), taurine, stabiliser (466).
Contains soy and milk ingredients.
Nutrition Information
RELATED PRODUCTS
RELATED CONTENT
Examining guidelines and new evidence in oncology nutrition
Examining guidelines and new evidence in oncology nutrition
- Logo
-
- Main Image
-
- Tagname
- Article
- Logo link
- title
- Examining guidelines and new evidence in oncology nutrition: a position paper on gaps and opportunities in multimodal approaches to improve patient care
- Content Reference
- /content/an/hcpproconnect/hk/en/home/adult/resources/public/Examining-guidelines-and-new-evidence-in-oncology-nutrition-a-position-paper-on-gaps-and-opportunities-in-multimodal-approaches-to-improve-pati
- Abstract
-
Malnutrition, muscle loss, and cachexia are prevalent in cancer and remain key challenges in oncology today. These conditions are frequently underrecognised and undertreated and have devastating consequences for patients. Early nutrition screening/assessment and intervention are associated with improved patient outcomes.
- Publish Date:
- Oct 2021
The Benefits of Beta-Hydroxy-Beta-Methylbutyrate (or HMB)
- Logo
-
- Main Image
-
- Tagname
- ARTICLE
- Logo link
- title
- The Benefits of Beta-Hydroxy-Beta-Methylbutyrate (or HMB)
- Content Reference
- /content/an/hcpproconnect/hk/en/home/adult/resources/public/hmb-article
- Abstract
-
The benefits of oral nutritional supplements containing HMB are supported by evidence from over 18 clinical studies,9-27 read this short article to learn more about the benefits of HMB.
- Publish Date:
The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition
The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition
- Logo
-
- Main Image
-
- Tagname
- Article
- Logo link
- title
- The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition
- Content Reference
- /content/an/hcpproconnect/hk/en/home/adult/resources/public/The-Underappreciated-Role-of-Low-Muscle-Mass-in-the-Management-of-Malnutrition
- Abstract
-
This opinion article, published in Journal of American Medical Directors Association (JAMDA), addresses the role of muscle mass in improving health outcomes in a variety of disease states. It also offers strategies you can use to help patients manage low muscle mass and prevent muscle loss.
- Publish Date:
- Jan 2019
Footnotes:
§ GI: Nepro®HP = 35
References:
- Study performed on prior liquid Nepro formulation. Caglar K, et al. Kidney Int. 2002; 62(3):1054-1059
- Sezer S, et al. JPEN J Parenter Enteral Nutr. 2014; 38:960-965
HKG.2025.58198.AND.1
Stay Connected